| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $392K | — | -23.2% |
| Cost of Revenue | $155K | — | -35.7% |
| Gross Profit | $237K | — | -12.2% |
| R&D Expense | $55K | — | -71.8% |
| SG&A Expense | $271K | — | -3.5% |
| Operating Income | -$1.3M | — | +11.8% |
| Interest Expense | $3K | — | -30.9% |
| Pre-tax Income | -$1.4M | — | +4.9% |
| Income Tax | $0 | — | — |
| Net Income | -$1.4M | — | +4.9% |
| EPS (Basic) | -$0.75 | — | +50.7% |
| EPS (Diluted) | -$0.75 | — | +50.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $313K | -55.7% | — |
| Accounts Receivable | $49K | +33.3% | -48.6% |
| Inventory | $735K | -23.7% | -46.7% |
| Current Assets | $1.3M | -35.2% | -54.8% |
| Total Assets | $1.6M | -30.6% | -50.8% |
| Current Liabilities | $8.3M | +5.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$485K | — | +35.5% |
| Investing Cash Flow | -$150K | — | +0.0% |
| Financing Cash Flow | $92K | — | -93.9% |
| +26.5% |
| Total Liabilities | $8.5M | +3.7% | +19.5% |
| Stockholders' Equity | -$6.9M | -17.5% | -81.2% |